ENVB
NASDAQ · Pharmaceuticals
Enveric Biosciences Inc
$2.85
-0.32 (-10.09%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+247.7% upside
Low Target
$5.56
Average Target
$9.91
High Target
$13.09
Current Price
$2.85
Current
$2.85
$2.85
Target
$9.91
$9.91
$5.56
$9.91 avg
$13.09
Scenario Analysis
Bear Case
$5.56
95.1%
Low target
Base Case
$9.91
+247.7%
Avg target
Bull Case
$13.09
+359.3%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$17.84
-84.0% from high
52-Week Low
$1.71
+66.7% from low
Target vs 52W High
$9.91
-44.5% vs high
Next Earnings Report
May 12, 2026
Today
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals